Anderson Kirstie N, Keogh Michael J, Gosse Luca
Institute of Neuroscience, Newcastle University Medical School, Newcastle Upon Tyne, UK.
Department of Neurology, Newcastle Upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.
Nat Sci Sleep. 2025 Jun 28;17:1521-1537. doi: 10.2147/NSS.S478860. eCollection 2025.
Sleep disturbance in Parkinson's disease (PD) is recognized to be one of the most common non-motor complications. It occurs before disease onset as a prodromal symptom, during and then throughout the disease course. Causes are multifactorial and can be multiple in the same patient. Specific sleep disorders that are known to occur in those with Parkinson's disease include REM sleep behavior disorder, sleep disordered breathing including obstructive sleep apnea, restless legs and periodic limb movements, nightmare disorder, insomnia alongside direct side-effects of the medication used for therapy. One key question is whether these sleep disorders impact upon the motor and non-motor symptoms of Parkinson's disease. There has been significant interest in recent years in using certain sleep disorders, in particular, REM sleep behavior disorder, as a biomarker both for those at risk of Parkinson's disease but also influencing the subsequent severity and speed of progression. However, other sleep disorders in the general population may also increase the risk of developing Parkinson's disease. It is important to understand whether the treatment of sleep disturbance and specific sleep disorders modifies the long-term risk of developing Parkinson's disease or its progression.
帕金森病(PD)中的睡眠障碍被认为是最常见的非运动并发症之一。它在疾病发作前作为前驱症状出现,在疾病过程中以及整个病程中都会出现。其病因是多因素的,同一患者可能存在多种原因。已知帕金森病患者会出现的特定睡眠障碍包括快速眼动睡眠行为障碍、睡眠呼吸障碍(包括阻塞性睡眠呼吸暂停)、不宁腿和周期性肢体运动、噩梦障碍、失眠以及治疗所用药物的直接副作用。一个关键问题是这些睡眠障碍是否会影响帕金森病的运动和非运动症状。近年来,人们对利用某些睡眠障碍,特别是快速眼动睡眠行为障碍,作为帕金森病风险人群的生物标志物以及影响其后续严重程度和进展速度产生了浓厚兴趣。然而,普通人群中的其他睡眠障碍也可能增加患帕金森病的风险。了解睡眠障碍和特定睡眠障碍的治疗是否会改变患帕金森病的长期风险或其进展情况非常重要。